cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Putri Bungsu
Contact Email
jurnalepidkes@ui.ac.id
Phone
-
Journal Mail Official
jurnalepidkes@ui.ac.id
Editorial Address
Jurnal Epidemiologi Kesehatan Indonesia Gd. A Lt. 1 FKM UI
Location
Kota depok,
Jawa barat
INDONESIA
Jurnal Epidemiologi Kesehatan Indonesia
Published by Universitas Indonesia
ISSN : -     EISSN : 2548513X     DOI : https://doi.org/10.7454/epidkes
Core Subject : Health, Science,
Health Professions Immunology & microbiology Medicine & Pharmacology Nursing Public Health
The article published on this journal can be editorial, research result and article review in public health, specifically epidemiology fields (Epidemiology of Infectious Disease, Epidemiology of Non-Communicable Disease, Epidemiology of Occupational Health and Safety, Epidemiology of Enviromental Health ond Biomarkers, Social and Behavioral Epidemiology, Epidemiology of Health Care, Epidemiology of Injury, Cancer Epidemiology, Epidemiology of Reproductive Health, Nutritional Epidemiology, Perinatal Epidemiology and Disaster Epidemiology). Epidemiology Health Promotion and Behavior Occupational Health and Safety Health Administration & Policy Environmental Health Health Communication Public Health Nutrition Biostatistics Reproductive Health Population Studies Health Informatics
Arjuna Subject : Profesi Kesehatan - Profesi Kesehatan (Lain-Lain)
Articles 12 Documents
 1   2 
Search results for , issue "Vol. 8, No. 2" : 12 Documents clear
Karakteristik dan Analisis Risiko Kasus Tuberkulosis di Puskesmas Senen Jakarta Pusat tahun 2023 Susanti, Eka Lusi; Hasnaini, Anna; -, Murniaty
Jurnal Epidemiologi Kesehatan Indonesia Vol. 8, No. 2
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Indonesiaranks second globally with the highest number of Tuberculosis (TB) cases, following India. Consequently, TB remains a high-priority health issue requiring immediate attention. This study aims to describe the TB case characteristic and analyze the TB risk in each urban villages of Senen, Central Jakarta. This is a descriptive cross-sectional study. Data was obtained from medical records and the Tuberculosis Information System (SITB) at Senen Primary Health Care (PHC) during January – December2023. Demographic data, TB type, result of rapid molecular test, and comorbidities were presented in numbers and percentages. Total TB cases, incidence rate (IR), and standardized morbidity ratio (SMR) were calculated for each urban villages and the entire subdistrict. The distribution of the number of cases, IR, and SMR was displayed on a map. Overall, 300 TB cases were found among 3,421 suspected TB cases examined at the Senen PHC in 2023, with a positivity rate of 7.22% and an incidence rate of 240 per 100,000 population. The highest number of TB cases occurred in September 2023 with 52 cases (17.33%). Of the total TB cases in Senen, TB cases were commonly found in males (67.67%), the productive age group (15-59 years) accounted for73.33%,new TB cases accounted for 93.33%, 100% were pulmonary TB cases, 82.33% were bacteriologically confirmed with 93.36% of them being drug-sensitive TB (DS-TB), smokers (73.33%) and employed (72.67%). TB cases were spread across sixurban villages, with Kramat having the highest number of cases at 98 (32.67%), a TB IR of 78 per 100,000 population, and an SMR of 0.71. TB cases occurred throughout the year in the Senen Subdistrict. The characteristics of TB cases in Senen were dominated by males, productive age groups, pulmonary TB, new cases, bacteriologically confirmed cases, DS-TB, smokers, and employed individuals. The TB risk varied in each area, with the highest number of cases, IR, and SMR found in Kramat urban village A comprehensive strategy combining early detection, effective treatment, and preventive measures is essential to control the TB epidemic in the Senen Subdistrict.
Hubungan antara Hipertensi dan Kematian Pasien COVID-19 di Layanan Rawat Inap RSUD Tarakan Tahun 2022 (Association between Hypertension and Mortality of COVID-19 Inpatients at Tarakan Regional General Hospital in 2022) Widyasari, Karina; Sudaryo, Mondastri Korib
Jurnal Epidemiologi Kesehatan Indonesia Vol. 8, No. 2
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Coronavirus Disease 2019 (COVID-19) is an infectious disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). COVID-19 was the leading disease in terms of the highest number of hospital admissions and cause of death at the Tarakan Regional General Hospital (RSUD Tarakan) in 2022. COVID-19 patients who received treatment at the hospital were often individuals with underlying conditions, such as hypertension. Therefore, it is important to conduct research on comorbidities, specifically hypertension, and its relationship to COVID-19 mortality at the RSUD Tarakan’s inpatient in 2022, so the hospital can design spesific care plans for COVID-19 patients with hypertension. This study used a retrospective cohort design with secondary data from the RSUD Tarakan's SIMRS reports. A total of 534 samples met the criteria for analysis. The variables measured included COVID-19 mortality, patient’s age and gender, hypertension, type 2 Diabetes Mellitus (DM), heart failure, Chronic Kidney Disease (CKD), Acute Kidney Injury (AKI), sepsis, and Acute Respiratory Distress Syndrome (ARDS). Analysis was performed using cox proportional hazards regression. The results showed a significant association between hypertension and COVID-19 mortality (aRR= 0.406; 95% CI 0.250-0.659; p-value: 0.000) after controlling for age. This indicates that patients with hypertension were 59.4% less likely to die from COVID-19 compared to those without hypertension. It is important to note that there are other factors that were not considered in this study. Therefore, the researchers suggest conducting further studies which take into account the severity of hypertension and the impact of antihypertensive treatment on COVID-19 mortality.

Page 2 of 2 | Total Record : 12

 1   2 

Filter by Year

2024 2024


Reset
Filter By Issues
All Issue Vol. 9, No. 2 Vol. 9, No. 1 Vol. 8, No. 2 Vol. 8, No. 1 Vol. 7, No. 2 Vol. 7, No. 1 Vol. 6, No. 2 Vol. 6, No. 1 Vol. 2, No. 2 Vol. 2, No. 1 Vol. 1, No. 2 Vol. 1, No. 1 More Issue